Screener
Relmada Therapeutics, Inc. RLMD Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding | - | - |
| Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding | - | - |
| Common stock, $0.001 par value, 150,000,000 shares authorized, 104,890,223 and 73,333,622 shares issued and outstanding, respectively | 104,890 | 73,333 |
| Additional paid-in capital | 935,946,841 | 784,705,878 |
| Accumulated deficit | (717,319,154) | (698,267,198) |
| Total stockholders’ equity | 218,732,577 | 86,512,013 |
| Total liabilities and stockholders’ equity | $235,362,794 | $94,003,471 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s retained earnings?
- Relmada Therapeutics, Inc. (RLMD) reported retained earnings of -$717.32M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s retained earnings changed year-over-year?
- Relmada Therapeutics, Inc.'s retained earnings decreased by 8.9% year-over-year, from -$658.44M to -$717.32M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s retained earnings has grown at a 31.2% compound annual growth rate (CAGR), from -$179.32M to -$698.27M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Relmada Therapeutics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude